IRIS
STUCCI, LUIGIA STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.789
AS - Asia 1.461
EU - Europa 1.379
SA - Sud America 356
AF - Africa 80
OC - Oceania 3
Totale 7.068
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.716
SG - Singapore 576
IT - Italia 438
CN - Cina 330
BR - Brasile 277
SE - Svezia 194
RU - Federazione Russa 184
HK - Hong Kong 153
VN - Vietnam 133
DE - Germania 108
GB - Regno Unito 106
FR - Francia 95
FI - Finlandia 72
IN - India 50
BD - Bangladesh 42
CA - Canada 42
UA - Ucraina 31
ID - Indonesia 30
CI - Costa d'Avorio 29
NL - Olanda 29
AR - Argentina 27
BE - Belgio 23
TR - Turchia 20
ZA - Sudafrica 18
IQ - Iraq 17
ES - Italia 16
SA - Arabia Saudita 15
CO - Colombia 14
IE - Irlanda 14
JP - Giappone 14
PL - Polonia 14
MX - Messico 13
NP - Nepal 13
AT - Austria 11
CL - Cile 11
LT - Lituania 9
MY - Malesia 8
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 8
AL - Albania 7
EC - Ecuador 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
KR - Corea 6
MA - Marocco 6
TN - Tunisia 6
RO - Romania 5
VE - Venezuela 5
GR - Grecia 4
IR - Iran 4
TH - Thailandia 4
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
PT - Portogallo 2
AM - Armenia 1
BJ - Benin 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MQ - Martinica 1
MR - Mauritania 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SI - Slovenia 1
Totale 7.064
Salva come PNG Salva come JPEG
Città #
Ashburn 457
Fairfield 373
Singapore 330
Woodbridge 318
Chandler 301
San Jose 189
Houston 183
Seattle 162
Nyköping 159
Cambridge 149
Hong Kong 146
Milan 142
Beijing 130
Wilmington 126
Ann Arbor 116
Jacksonville 74
New York 73
Los Angeles 72
Rome 54
Lauterbourg 53
Dallas 51
Lawrence 49
Helsinki 47
Roxbury 47
Nanjing 46
Bari 44
Ho Chi Minh City 38
Munich 35
Des Moines 33
Abidjan 29
Brooklyn 27
Inglewood 27
Santa Clara 27
São Paulo 24
Brussels 22
Princeton 22
Hanoi 21
London 21
Paris 19
Council Bluffs 18
San Diego 18
Chicago 17
Jakarta 17
Dong Ket 16
Montreal 16
Buffalo 15
Nuremberg 15
Boardman 14
Columbus 14
Denver 14
Dublin 14
North Bergen 14
Poplar 14
Redwood City 13
Tokyo 12
Chennai 11
Curitiba 11
Amsterdam 10
Figino 10
Frankfurt am Main 10
Orem 10
Stockholm 10
Toronto 10
Warsaw 10
Washington 10
Dearborn 9
Kathmandu 9
Moscow 9
Nanchang 9
Phoenix 9
Belo Horizonte 8
Düsseldorf 8
Hebei 8
Johannesburg 8
Ottawa 8
Porto Alegre 8
Santiago 8
The Dalles 8
Atlanta 7
Dhaka 7
Manchester 7
New Delhi 7
Palermo 7
Tashkent 7
Tianjin 7
Amman 6
Baghdad 6
Bologna 6
Da Nang 6
Hải Dương 6
Rio de Janeiro 6
San Mateo 6
Shenyang 6
Turin 6
Vienna 6
Augusta 5
Bogotá 5
Haiphong 5
Marseille 5
Mexico City 5
Totale 4.822
Salva come PNG Salva come JPEG
Nome #
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 215
Adenocarcinoma of the ceruminous glands: role of the VMAT 196
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 195
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 180
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 179
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 179
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 178
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 178
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 177
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 172
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 171
Avβ3 integrin: Pathogenetic role in osteotropic tumors 168
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 166
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 165
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 165
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 158
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 155
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 153
null 149
Reframing Breast Cancer Experience through Metaphors: A New Operative System to Enhance Patients’ Healing Process 149
Does cilengitide deserve another chance? 144
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 144
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 143
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 142
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 139
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 136
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 136
Current status and perspectives in immunotherapy for metastatic melanoma 134
COVID 19: HEALTH, STATISTICAL AND CONSTITUTIONAL ASPECTS 132
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 130
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 126
miRNAs in melanoma: a defined role in tumor progression and metastasis 119
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 117
The immune escape in melanoma: role of the impaired dendritic cell function 113
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 113
[Novel markers in osteo-oncology: the tartrate resistant acid phosphatase in myeloma bone disease]. FT Alla ricerca di nuovi marcatori in osteo-oncologia: la fosfatasi acida tartrato-resistente nella malattia ossea mielomatosa 110
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 110
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 107
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 101
Clinical nutrition in surgical oncology: Young AIOM-AIRO-SICO multidisciplinary national survey on behalf of NutriOnc research group 100
A large metastatic intramammary lesion of an occult melanoma 97
Non-Melanoma Skin Cancers: Biological and Clinical Features 97
Dietary compounds and cutaneous malignant melanoma: Recent advances from a biological perspective 95
Characterization of the metastatic behavior and gene expression profile (RNAseq) of different melanoma cell lines: a comprehensive in vivo model. 95
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: A potential role as additional prognostic marker 91
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice 87
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery 80
Effect of age on melanoma risk, prognosis and treatment response 80
null 78
Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker. 76
Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma. 71
null 66
null 62
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 59
null 57
Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence? 55
Te avbeta3/avbeta5 blockage by Cilengitide disables the osteoclast-like differentiation of malignant plasma cells in multiple myeloma 43
Does clilengitide deserve another chance? 40
null 33
Totale 7.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.294
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.294
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022374 18 21 5 17 15 38 9 20 32 37 63 99
2022/2023727 106 98 46 70 69 100 14 85 107 7 15 10
2023/2024310 16 49 18 51 30 66 11 20 8 4 3 34
2024/20251.130 37 14 98 60 40 91 130 112 75 64 137 272
2025/20262.542 383 112 156 260 344 130 234 93 282 233 75 240
2026/202748 48 0 0 0 0 0 0 0 0 0 0 0
Totale 7.306